{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:30:53Z","timestamp":1790163053651,"version":"4.1.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1998,9]]},"DOI":"10.1212\/wnl.51.3.811","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:35:51Z","timestamp":1336916151000},"page":"811-814","source":"Crossref","is-referenced-by-count":122,"title":["Early dopaminergic drug-induced hallucinations in parkinsonian patients"],"prefix":"10.1212","volume":"51","author":[{"given":"Christopher G.","family":"Goetz","sequence":"first","affiliation":[{"name":"From the Department of Neurological Sciences (Drs. Goetz and Stebbins), Rush University\/Rush Presbyterian St. Luke's Medical Center, Chicago, IL; the private practice of Dr. Vogel, Indianapolis, IN; and the Parkinson's Institute (Dr. Tanner), Sunnyvale, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caryn","family":"Vogel","sequence":"additional","affiliation":[{"name":"From the Department of Neurological Sciences (Drs. Goetz and Stebbins), Rush University\/Rush Presbyterian St. Luke's Medical Center, Chicago, IL; the private practice of Dr. Vogel, Indianapolis, IN; and the Parkinson's Institute (Dr. Tanner), Sunnyvale, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline M.","family":"Tanner","sequence":"additional","affiliation":[{"name":"From the Department of Neurological Sciences (Drs. Goetz and Stebbins), Rush University\/Rush Presbyterian St. Luke's Medical Center, Chicago, IL; the private practice of Dr. Vogel, Indianapolis, IN; and the Parkinson's Institute (Dr. Tanner), Sunnyvale, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn T.","family":"Stebbins","sequence":"additional","affiliation":[{"name":"From the Department of Neurological Sciences (Drs. Goetz and Stebbins), Rush University\/Rush Presbyterian St. Luke's Medical Center, Chicago, IL; the private practice of Dr. Vogel, Indianapolis, IN; and the Parkinson's Institute (Dr. Tanner), Sunnyvale, CA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"e_1_3_1_2_2","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington DC: American Psychiatric Association 1994."},{"key":"e_1_3_1_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(95)91146-4"},{"key":"e_1_3_1_4_2","first-page":"4","volume":"139","year":"1982","unstructured":"Goetz CG, Tanner CM, Klawans HL. Pharmacology of hallucinations induced by long-term drug therapy. Am J Psychol 1982;139:494-498.","journal-title":"Am J Psychol"},{"key":"e_1_3_1_5_2","first-page":"2","volume":"7","year":"1992","unstructured":"Langston JW, Widner H, Goetz CG, et al. Core Assessment Program for Intracerebral Transplantations (CAPIT). Mov Disord 1992;7:2-13.","journal-title":"Mov Disord"},{"key":"e_1_3_1_6_2","first-page":"2","volume":"2","year":"1882","unstructured":"Ball B. De l'insanit\u00e9 dans la paralysie agitante. Enc\u00e9phale 1882;2:22-32.","journal-title":"Enc\u00e9phale"},{"key":"e_1_3_1_7_2","first-page":"4","volume":"10","year":"1883","unstructured":"Parant V. La paralysie agitante examin\u00e9e comme cause de folie. Ann Med Psychol (Paris) 1883;10:45-63.","journal-title":"Ann Med Psychol (Paris)"},{"key":"e_1_3_1_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870100102"},{"key":"e_1_3_1_9_2","first-page":"8","volume":"44","year":"1994","unstructured":"McKeith IG, Fairbairn AF, Bothwell RA, Poore PB. An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of Lewy body type. Neurology 1994;44:872-877.","journal-title":"Neurology"},{"key":"e_1_3_1_10_2","first-page":"9","volume":"55","year":"1998","unstructured":"Litvan I, MacIntyre A, Goetz CG, Wenning GK, Jellinger K. Accuracy of the clinical diagnosis of Lewy body disease, Parkinson's disease and dementia with Lewy bodies: a clinico-pathologic study. Arch Neurol 1998;55:969-978.","journal-title":"Arch Neurol"},{"key":"e_1_3_1_11_2","first-page":"2","volume":"44","year":"1994","unstructured":"Stern Y, Albert M, Brandt J. Utility of extrapyramidal signs and psychosis as predictors of cognitive and functional decline, nursing home admission and death in Alzheimer's disease: prospective analyses from the predictors study. Neurology 1994;44:2300-2307.","journal-title":"Neurology"},{"key":"e_1_3_1_12_2","first-page":"1","volume":"53","year":"1996","unstructured":"Kendler KS, Gallagher TU, Abelson JM. Life time prevalence, demographic risk factors and diagnostic validity of non-affective psychosis as assessed in a US community sample: the National Co-morbidity Survey. Arch Gen Psychiatry 1996;53:1022-1031.","journal-title":"Arch Gen Psychiatry"},{"key":"e_1_3_1_13_2","first-page":"8","volume":"142","year":"1995","unstructured":"Mayeux T, Marder K, Cot\u00e9 LJ. The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993. Am J Epidemiol 1995;142:820-827.","journal-title":"Am J Epidemiol"},{"key":"e_1_3_1_14_2","unstructured":"Aarli JA Gilhus NE. Sinemet CR in the treatment of patients with Parkinson's disease already on long-term treatment with levodopa. Neurology 1989;39(suppl 2):82-85."},{"key":"e_1_3_1_15_2","doi-asserted-by":"crossref","unstructured":"Rinne UK. Deprenyl (selegiline) in the treatment of Parkinson's disease. Acta Neurol Scand 1983;95(suppl):107-111.","DOI":"10.1111\/j.1600-0404.1983.tb01523.x"},{"key":"e_1_3_1_16_2","first-page":"2","volume":"12","year":"1982","unstructured":"Lang AE, Quinn N, Brincat S. Pergolide in late-stage Parkinson's disease. Ann Neurol 1982;12:243-247.","journal-title":"Ann Neurol"},{"key":"e_1_3_1_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410140102"},{"key":"e_1_3_1_18_2","first-page":"2","volume":"43","year":"1993","unstructured":"Goetz CG, Stebbins GT. Risk factors for nursing home placement in advanced Parkinson's disease. Neurology 1993;43:2227-2229.","journal-title":"Neurology"},{"key":"e_1_3_1_19_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.45.1.6"}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.51.3.811","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T14:43:10Z","timestamp":1711550590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.51.3.811"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,9]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1998,9]]}},"alternative-id":["10.1212\/WNL.51.3.811"],"URL":"https:\/\/doi.org\/10.1212\/wnl.51.3.811","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,9]]}}}